Ultimate Longevity Bible

Disease of aging

Sarcopenia

Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

What it is

Sarcopenia is age-related loss of skeletal muscle quantity and quality. The EWGSOP2 definition requires:

  • Low muscle strength (grip strength or chair-rise) — the defining criterion.
  • Low muscle quantity or quality (DEXA appendicular lean mass index, ultrasound, BIA).
  • Optionally: low physical performance (gait speed) for severity.

Why it matters

  • Muscle mass and strength independently predict all-cause mortality.
  • Underlies most falls and hip fractures in older adults.
  • Worsens insulin resistance, cardiometabolic risk.
  • Reduces resilience to surgery, hospitalisation, and acute illness.

Risk factors

  • Inactivity (the dominant cause).
  • Inadequate protein intake.
  • Inflammation, chronic disease (cancer, CKD, COPD).
  • Hormonal (low testosterone, menopausal estrogen loss).
  • Vitamin D deficiency.
  • Prolonged bed rest / immobilisation.

What works

  • Resistance training (the single most effective intervention; gains possible even in 90-year-olds).
  • Adequate protein (1.2–1.6 g/kg/day in older adults, distributed across meals).
  • Creatine monohydrate amplifies training response.
  • Treat reversible contributors: vitamin D, hypogonadism, depression.
  • Avoid sedentary recovery after acute illness.

Related entries

Grip strength, DEXA scan, Exercise, Protein and mTOR.

References

  • Cruz-Jentoft, A. J. et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age Ageing 48, 16–31 (2019).

More diseases